latam

Regístrate
Invertir conlleva riesgos y puede no ser adecuado para todos los inversores.

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Inicio・Lista de Acciones・BioNTech SE ADR
Search

BioNTech SE ADR

Cerrado

Sector Salud

89.58 -0.49

Comprar

Precios actualizados 6 sept 2024, 19:59 UTC

ComprarVender

Resumen

Variación precio

24h

Actual

Mínimo

88.71

Máximo

90.18

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+20.24 upside

Dividendos

By Dow Jones

Próximas Ganancias

4 nov 2024

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

114 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

88.19 / 90.24 Soporte y Resistencia

BioNTech SE ADR Gráfico

Noticias Relacionadas

6 may 2024, 11:27 UTC

Ganancias

BioNTech Swings to Net Loss on Lower Covid Vaccine Sales

DJ

Leer

20 mar 2024, 10:44 UTC

Ganancias

BioNTech Profit Slumps on Lower Covid Vaccine Sales

DJ

Leer

8 feb 2024, 11:43 UTC

Adquisiciones, fusiones, absorciones

BioNTech Agrees To Invest $200 Million in Autolus, Starts Strategic Collaboration

DJ

Leer

5 ago 2024, 10:02 UTC

Ganancias

BioNTech Sees 2024 R&D Expenses EUR2.4B-EUR2.6B >BNTX

DJ

Leer

5 ago 2024, 10:01 UTC

Ganancias

BioNTech Backs 2024 View of Rev EUR2.5B-EUR3.1B >BNTX

DJ

Leer

5 ago 2024, 10:01 UTC

Ganancias

BioNTech: Invested EUR525.6M, or About 90% of 2Q R&D Spend, in Non-Covid-19 Related Activities >BNTX

DJ

Leer

5 ago 2024, 10:00 UTC

Ganancias

BioNTech 2Q-End Cash, Equivalents, Security Investments EUR18.5 Billion >BNTX

DJ

Leer

5 ago 2024, 09:59 UTC

Ganancias

BioNTech 2Q Loss EUR807.8M >BNTX

DJ

Leer

5 ago 2024, 09:59 UTC

Ganancias

BioNTech 2Q Loss/Shr EUR3.36 >BNTX

DJ

Leer

5 ago 2024, 09:59 UTC

Ganancias

BioNTech 2Q Rev EUR128.7M >BNTX

DJ

Leer

6 may 2024, 20:15 UTC

Ganancias

BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come -- IBD

DJ

Leer

6 may 2024, 10:47 UTC

Ganancias

BioNTech Sees FY24 Rev EUR2.5B-EUR3.1B >BNTX

DJ

Leer

6 may 2024, 10:46 UTC

Ganancias

Correct: BioNTech 1Q Loss/Shr EUR1.31 >BNTX

DJ

Leer

6 may 2024, 10:46 UTC

Ganancias

Correct: BioNTech 1Q Loss EUR315.1M >BNTX

DJ

Leer

6 may 2024, 10:46 UTC

Ganancias

Correct: BioNTech 1Q Rev EUR187.6M >BNTX

DJ

Leer

6 may 2024, 10:45 UTC

Ganancias

BioNTech 1Q Rev $187.6M >BNTX

DJ

Leer

6 may 2024, 10:45 UTC

Ganancias

BioNTech 1Q Loss $315.1M >BNTX

DJ

Leer

6 may 2024, 10:45 UTC

Ganancias

BioNTech 1Q Loss/Shr $1.31 >BNTX

DJ

Leer

26 mar 2024, 05:00 UTC

Ganancias

This Vaccine Maker Sits on Cash Almost Equal to Its Market Value -- Barrons.com

DJ

Leer

20 mar 2024, 11:44 UTC

Ganancias

BioNTech Earnings Fall Short of Estimates. The Stock Is Down. -- Barrons.com

DJ

Leer

20 mar 2024, 10:27 UTC

Ganancias

BioNTech's Stock Sinks After Earnings Fall Below Expectations, Hurt By Writedowns Of Vaccine Inventory -- MarketWatch

DJ

Leer

20 mar 2024, 10:17 UTC

Ganancias

BioNTech 4Q Rev EUR1.48B >BNTX

DJ

Leer

20 mar 2024, 10:15 UTC

Ganancias

Biontech 4Q Net Pft EUR457.9M

DJ

Leer

20 mar 2024, 10:15 UTC

Ganancias

Biontech Plans For Ten or More Registrational Oncology Trials By End of 2024

DJ

Leer

20 mar 2024, 10:15 UTC

Ganancias

Biontech: Annemarie Hanekamp appointed to Management Board as Chief Commercial Officer, effective Jul. 1

DJ

Leer

20 mar 2024, 10:15 UTC

Ganancias

Biontech Aims For First Oncology Launch in 2026 and Ten Indication Approvals by 2030

DJ

Leer

20 mar 2024, 10:15 UTC

Ganancias

Biontech 2023 Gross Profit For COVID-19 Vaccine Business EUR3.2B

DJ

Leer

20 mar 2024, 10:15 UTC

Ganancias

Biontech Sees 2024 Revenue Between EUR2.5B - EUR3.1B

DJ

Leer

20 mar 2024, 10:15 UTC

Ganancias

Biontech 4Q Rev EUR1.48B

DJ

Leer

8 feb 2024, 11:28 UTC

Adquisiciones, fusiones, absorciones

BioNTech Agrees To Invest $200 Mln in Autolus, Starts Strategic Collaboration

DJ

Leer

Comparación entre iguales

Cambio de precio

BioNTech SE ADR Esperado

Precio Objetivo

By TipRanks

20.24% repunte

Estimación a 12 meses

Media 108.4 USD  20.24%

Máximo 171 USD

Mínimo 85 USD

De acuerdo con 13 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para BioNTech SE ADR Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

13 ratings

6

Comprar

6

Mantener

1

Vender

De acuerdo con 13 analistas que ofrecen calificaciones bursátiles a para BioNTech SE ADR Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

88.19 / 90.24Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

All events are bullish.

Medio plazo

Bullish Evidence

Recent bullish events outweigh bearish events.

Largo Plazo

Bearish Evidence

All events are bearish.

Sentimiento

By Acuity

114 / 365 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Otras acciones del sector

LLY

Eli Lilly and Co.

902.74

↓-0.9%

UNH

UnitedHealth Group Inc

596.8

↑ +0.31%

NVO

Novo Nordisk A-S

131.05

↑ +0.18%

JNJ

Johnson and Johnson

164.37

↓-0.29%

ABBV

AbbVie Inc

193.18

↑ +0.34%